| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
2007-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c95eb31656d5b792d7b74705353b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104323988d6242b525fa48420ff29c82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce1294ebc74a017d4af9698e3d9eb1c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87192f4b71474959cb96ccf59f6db125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ff13e6d79a28a307f47d2bfa4820d22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_105f31c5aff74a353468dafc5501266f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d7ba758af443429e5cfd417d3d20e62 |
| publicationDate |
2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2484967-T3 |
| titleOfInvention |
Antibodies against beta-amyloid peptide |
| abstract |
A therapeutic antibody that is an antibody or antigen-binding fragment and / or derivative thereof that binds to the β-amyloid peptide and which comprises the following CDR: CDRH1: DNGMA (SEQ ID NO: 1) CDRH2: FISNLAYSIDYADTVTG ( SEQ ID NO: 2) CDRH3: GTWFAY (SEQ ID NO: 3) within a framework of a variable region of human heavy chain originating from the VH3 family of genes and: CDRL1: RVSQSLLHSNGYTYLH (SEC ID NO: 4) CDRL2: KVSNRFS (SEQ ID NO: 5) CDRL3: SQTRHVPYT (SEQ ID NO: 6) within a framework of a variable region of human light chain originating from the amino acid sequence disclosed in SEQ ID NO: 24. |
| priorityDate |
2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |